Danaher acquires Nobel Biocare Holding

Danaher acquiers Nobel Biocare Holding

Danaher acquiers Nobel Biocare Holding

US technology and science conglomerate Danaher Corporation, headquartered in Washington D.C., United Sates agreed to acquire Nobel Biocare Holding , Swiss dental implant maker, for about $2.2 billion. Danaher offered to acquire all oustanding shares for 17.10 Swiss francs, or about $18.31,a piece.

“This combination will help us build a strong platform for future growth,” Henk van Duijnhoven, the senior vice president of Danaher’s dental business, said in a news release.

This offer is recommended by Nobel board of directors to accept.

“We view Danaher as the ideal strategic partner for the sustainable development of Nobel Biocare,” Rolf Watter, the Nobel Biocare chairman, said in a news release.

Nobel Biocare offers dental implants, prosthetics and software used in planning dental surgery. Danaher provides technology products and services including health care, consumer goods and pharmaceuticals.

The offer is subject to regulatory approval. The offer is expected to be completed late this year or early in 2015.

 Nobel Biocare’s board of directors was advised by Goldman Sachs.

 Mr. Stakebay says:

Danaher annual sales from the dental industry will approach $3 billion after the purchase, giving it an “unmatched position” in dental implants as Nobel Biocare will expand the company’s presence in the premium segment of the market.

 

President and CEO of Danaher Corp…. Thomas P. Joyce, Jr…(2014-present)……$9 428 220 (2013)

CEO of Nobel Biocare Holding …………..Richard T. Laube…….(2011-present)……€2 059 000 (2013)

 

DANAHER CORPORATION

NOBEL BIOCARE HOLDING

Revenue

$ 19.118 Billion (2013)

€ 566.78 Million (2013)

Operating income

$ 3.275 Billion (2013)

€ 64.022 Million (2013)

Profit

$ 2.695 Billion (2013)

€ 42.579 Million (2013)

Total assets

$ 34.672 Billion (2013)

€ 609.925 Million (2013)

Total Equity

$ 22.45 Billion (2013)

€ 335.108 Million (2013)

Employees

66 000 (2013)

2487 (2013)

You Might Also Like

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>